Search for: "BRISTOL-MYERS SQUIBB" Results 361 - 380 of 863
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Apr 2015, 2:00 am
We reported to you last August on Bristol-Myers Squibb Co. v. [read post]
1 Apr 2015, 12:38 pm by Ryan S. Perlin
The Guatemala victims have also sued pharmaceutical manufacturer Bristol-Myers Squibb, which was also involved in the Guatemala Experiments. [read post]
1 Apr 2015, 12:38 pm by Ryan S. Perlin
The Guatemala victims have also sued pharmaceutical manufacturer Bristol-Myers Squibb, which was also involved in the Guatemala Experiments. [read post]
1 Apr 2015, 12:38 pm by Ryan S. Perlin
The Guatemala victims have also sued pharmaceutical manufacturer Bristol-Myers Squibb, which was also involved in the Guatemala Experiments. [read post]
24 Mar 2015, 11:54 am by Dr. Shezad Malik
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
22 Mar 2015, 9:46 pm by Patent Docs
Bristol-Myers Squibb Co. v. [read post]
22 Mar 2015, 9:46 pm by Patent Docs
Bristol-Myers Squibb Co. v. [read post]
13 Feb 2015, 12:00 pm by Greene LLP
At issue in the case were Bristol-Myers Squibb’s anticoagulant Coumadin and AstraZeneca’s ulcer drugs Prilosec and Nexium. [read post]
31 Jan 2015, 8:47 pm by Mark Summerfield
The issue of what, exactly, is ‘implicitly’ disclosed in a prior art reference arises in a decision of a full bench of the Federal Court issued on 23 January 2015 (Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2) in an appeal relating to a long-running dispute over the validity of a patent covering the antipsychotic drug aripiprazole. [read post]
21 Jan 2015, 3:02 pm
Its corporate talking heads (Bristol-Myers Squibb and Pfizer) said such spending helps ensure that providers understand its appropriate use, and how important it is “to have a speaker program that adequately provides robust education to these physicians. [read post]
20 Dec 2014, 10:53 am by Tom Lamb
That is, Bristol-Myers Squibb and Pfizer do not state in these advertisements that there is no FDA-approved antidote for Eliquis as regards its blood-thinner effect at this time. [read post]
18 Nov 2014, 9:44 pm by Lawrence B. Ebert
” from a post by Kelly Laycock.The logic and style of the arguments about patent examiners is indeed incomprehensible.Perhaps "patenthawk" should include law review articles, in addition to court decisions, within his scope; from a recent post on Bristol-Myers Squibb v. [read post]
7 Nov 2014, 5:52 am
We’ve made no secret of our distaste for the so called “heeding presumption” – that juries may presume that any alternative “adequate” warning would have been heeded by the plaintiff (or, in prescription medical product cases, the prescriber). [read post]
31 Oct 2014, 10:39 pm
Recently, NOACs have hit the market with FDA approval and are earning record profits for their respective manufacturers (Boehringer Ingelheim, Johnson & Johnson and Pfizer/Bristol Myers Squibb). [read post]